 | • レポートコード：B-GIR08C4329 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、PD-1阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ペンブロリズマブ、ニボルマブ、アテゾリズマブ、デュルバルマブ、アベルマブ、その他等、用途別セグメントは、等に区分しました。PD-1阻害剤の世界市場概観、企業動向、企業別PD-1阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・PD-1阻害剤の市場概観 ・PD-1阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・PD-1阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・PD-1阻害剤の世界市場規模 ・PD-1阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・PD-1阻害剤のアメリカ市場規模推移 ・PD-1阻害剤のカナダ市場規模推移 ・PD-1阻害剤のメキシコ市場規模推移 ・PD-1阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・PD-1阻害剤のドイツ市場規模推移 ・PD-1阻害剤のイギリス市場規模推移 ・PD-1阻害剤のロシア市場規模推移 ・PD-1阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・PD-1阻害剤の日本市場規模推移 ・PD-1阻害剤の中国市場規模推移 ・PD-1阻害剤の韓国市場規模推移 ・PD-1阻害剤のインド市場規模推移 ・PD-1阻害剤の東南アジア市場規模推移 ・PD-1阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・PD-1阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・PD-1阻害剤の種類別分析/販売量、売上、市場シェア（ペンブロリズマブ、ニボルマブ、アテゾリズマブ、デュルバルマブ、アベルマブ、その他） ・PD-1阻害剤の用途別分析/市場規模（） ・PD-1阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・PD-1阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global PD-1 Inhibitor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of PD-1 Inhibitor.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the PD-1 Inhibitor market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the PD-1 Inhibitor market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck
Novartis
Onxeo
Sumitomo Dainippon Pharma
Taiwan Liposome Company
Tiziana Life Sciences
Genentech (Roche)
AstraZeneca
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pembrolizumab
Nivolumab
Atezolizumab
Durvalumab
Avelumab
Other
Market Segment by Applications, can be divided into
Melanoma
Non-small Cell Lung Cancer (NSCLC)
Urothelial Carcinoma
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Table of Contents
1 PD-1 Inhibitor Market Overview
1.1 Product Overview and Scope of PD-1 Inhibitor
1.2 Classification of PD-1 Inhibitor by Types
1.2.1 Global PD-1 Inhibitor Revenue Comparison by Types (2019-2024)
1.2.2 Global PD-1 Inhibitor Revenue Market Share by Types in 2018
1.2.3 Pembrolizumab
1.2.4 Nivolumab
1.2.5 Atezolizumab
1.2.6 Durvalumab
1.2.7 Avelumab
1.2.8 Other
1.3 Global PD-1 Inhibitor Market by Application
1.3.1 Global PD-1 Inhibitor Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Melanoma
1.3.3 Non-small Cell Lung Cancer (NSCLC)
1.3.4 Urothelial Carcinoma
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global PD-1 Inhibitor Market by Regions
1.4.1 Global PD-1 Inhibitor Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) PD-1 Inhibitor Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) PD-1 Inhibitor Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) PD-1 Inhibitor Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) PD-1 Inhibitor Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) PD-1 Inhibitor Status and Prospect (2014-2024)
1.5 Global Market Size of PD-1 Inhibitor (2014-2024)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 PD-1 Inhibitor Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 PD-1 Inhibitor Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.3 Onxeo
2.3.1 Business Overview
2.3.2 PD-1 Inhibitor Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Onxeo PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sumitomo Dainippon Pharma
2.4.1 Business Overview
2.4.2 PD-1 Inhibitor Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.5 Taiwan Liposome Company
2.5.1 Business Overview
2.5.2 PD-1 Inhibitor Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Taiwan Liposome Company PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.6 Tiziana Life Sciences
2.6.1 Business Overview
2.6.2 PD-1 Inhibitor Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tiziana Life Sciences PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.7 Genentech (Roche)
2.7.1 Business Overview
2.7.2 PD-1 Inhibitor Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genentech (Roche) PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 PD-1 Inhibitor Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 PD-1 Inhibitor Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
3 Global PD-1 Inhibitor Market Competition, by Players
3.1 Global PD-1 Inhibitor Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 PD-1 Inhibitor Players Market Share
3.2.2 Top 10 PD-1 Inhibitor Players Market Share
3.3 Market Competition Trend
4 Global PD-1 Inhibitor Market Size by Regions
4.1 Global PD-1 Inhibitor Revenue and Market Share by Regions
4.2 North America PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
4.3 Europe PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
4.5 South America PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
5 North America PD-1 Inhibitor Revenue by Countries
5.1 North America PD-1 Inhibitor Revenue by Countries (2014-2019)
5.2 USA PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
5.3 Canada PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
5.4 Mexico PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
6 Europe PD-1 Inhibitor Revenue by Countries
6.1 Europe PD-1 Inhibitor Revenue by Countries (2014-2019)
6.2 Germany PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
6.3 UK PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
6.4 France PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
6.5 Russia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
6.6 Italy PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
7 Asia-Pacific PD-1 Inhibitor Revenue by Countries
7.1 Asia-Pacific PD-1 Inhibitor Revenue by Countries (2014-2019)
7.2 China PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
7.3 Japan PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
7.4 Korea PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
7.5 India PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
8 South America PD-1 Inhibitor Revenue by Countries
8.1 South America PD-1 Inhibitor Revenue by Countries (2014-2019)
8.2 Brazil PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
8.3 Argentina PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
8.4 Colombia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue PD-1 Inhibitor by Countries
9.1 Middle East and Africa PD-1 Inhibitor Revenue by Countries (2014-2019)
9.2 Saudi Arabia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
9.3 UAE PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
9.4 Egypt PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
9.5 Nigeria PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
9.6 South Africa PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
10 Global PD-1 Inhibitor Market Segment by Type
10.1 Global PD-1 Inhibitor Revenue and Market Share by Type (2014-2019)
10.2 Global PD-1 Inhibitor Market Forecast by Type (2019-2024)
10.3 Pembrolizumab Revenue Growth Rate (2014-2024)
10.4 Nivolumab Revenue Growth Rate (2014-2024)
10.5 Atezolizumab Revenue Growth Rate (2014-2024)
10.6 Durvalumab Revenue Growth Rate (2014-2024)
10.7 Avelumab Revenue Growth Rate (2014-2024)
10.8 Other Revenue Growth Rate (2014-2024)
11 Global PD-1 Inhibitor Market Segment by Application
11.1 Global PD-1 Inhibitor Revenue Market Share by Application (2014-2019)
11.2 PD-1 Inhibitor Market Forecast by Application (2019-2024)
11.3 Melanoma Revenue Growth (2014-2019)
11.4 Non-small Cell Lung Cancer (NSCLC) Revenue Growth (2014-2019)
11.5 Urothelial Carcinoma Revenue Growth (2014-2019)
11.6 Classical Hodgkin Lymphoma Revenue Growth (2014-2019)
11.7 Renal Cell Carcinoma Revenue Growth (2014-2019)
11.8 Other Revenue Growth (2014-2019)
12 Global PD-1 Inhibitor Market Size Forecast (2019-2024)
12.1 Global PD-1 Inhibitor Market Size Forecast (2019-2024)
12.2 Global PD-1 Inhibitor Market Forecast by Regions (2019-2024)
12.3 North America PD-1 Inhibitor Revenue Market Forecast (2019-2024)
12.4 Europe PD-1 Inhibitor Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific PD-1 Inhibitor Revenue Market Forecast (2019-2024)
12.6 South America PD-1 Inhibitor Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa PD-1 Inhibitor Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure PD-1 Inhibitor Picture
Table Product Specifications of PD-1 Inhibitor
Table Global PD-1 Inhibitor and Revenue (Million USD) Market Split by Product Type
Figure Global PD-1 Inhibitor Revenue Market Share by Types in 2018
Figure Pembrolizumab Picture
Figure Nivolumab Picture
Figure Atezolizumab Picture
Figure Durvalumab Picture
Figure Avelumab Picture
Figure Other Picture
Table Global PD-1 Inhibitor Revenue (Million USD) by Application (2014-2024)
Figure PD-1 Inhibitor Revenue Market Share by Applications in 2018
Figure Melanoma Picture
Figure Non-small Cell Lung Cancer (NSCLC) Picture
Figure Urothelial Carcinoma Picture
Figure Classical Hodgkin Lymphoma Picture
Figure Renal Cell Carcinoma Picture
Figure Other Picture
Table Global Market PD-1 Inhibitor Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global PD-1 Inhibitor Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck PD-1 Inhibitor Type and Applications
Table Merck PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis PD-1 Inhibitor Type and Applications
Table Novartis PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Onxeo Basic Information, Manufacturing Base and Competitors
Table Onxeo PD-1 Inhibitor Type and Applications
Table Onxeo PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table Sumitomo Dainippon Pharma PD-1 Inhibitor Type and Applications
Table Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Taiwan Liposome Company Basic Information, Manufacturing Base and Competitors
Table Taiwan Liposome Company PD-1 Inhibitor Type and Applications
Table Taiwan Liposome Company PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Tiziana Life Sciences Basic Information, Manufacturing Base and Competitors
Table Tiziana Life Sciences PD-1 Inhibitor Type and Applications
Table Tiziana Life Sciences PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) PD-1 Inhibitor Type and Applications
Table Genentech (Roche) PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca PD-1 Inhibitor Type and Applications
Table AstraZeneca PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer PD-1 Inhibitor Type and Applications
Table Pfizer PD-1 Inhibitor Revenue, Gross Margin and Market Share (2017-2018)
Table Global PD-1 Inhibitor Revenue (Million USD) by Players (2014-2019)
Table Global PD-1 Inhibitor Revenue Share by Players (2014-2019)
Figure Global PD-1 Inhibitor Revenue Share by Players in 2017
Figure Global PD-1 Inhibitor Revenue Share by Players in 2018
Figure Global Top 5 Players PD-1 Inhibitor Revenue Market Share in 2018
Figure Global Top 10 Players PD-1 Inhibitor Revenue Market Share in 2018
Figure Global PD-1 Inhibitor Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global PD-1 Inhibitor Revenue (Million USD) by Regions (2014-2019)
Table Global PD-1 Inhibitor Revenue Market Share by Regions (2014-2019)
Figure Global PD-1 Inhibitor Revenue Market Share by Regions (2014-2019)
Figure Global PD-1 Inhibitor Revenue Market Share by Regions in 2018
Figure North America PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Europe PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure South America PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table North America PD-1 Inhibitor Revenue by Countries (2014-2019)
Table North America PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure North America PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure North America PD-1 Inhibitor Revenue Market Share by Countries in 2018
Figure USA PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Canada PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Mexico PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table Europe PD-1 Inhibitor Revenue (Million USD) by Countries (2014-2019)
Figure Europe PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Europe PD-1 Inhibitor Revenue Market Share by Countries in 2018
Figure Germany PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure UK PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure France PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Russia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Italy PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table Asia-Pacific PD-1 Inhibitor Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific PD-1 Inhibitor Revenue Market Share by Countries in 2018
Figure China PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Japan PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Korea PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure India PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Southeast Asia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table South America PD-1 Inhibitor Revenue by Countries (2014-2019)
Table South America PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure South America PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure South America PD-1 Inhibitor Revenue Market Share by Countries in 2018
Figure Brazil PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Argentina PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Colombia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table Middle East and Africa PD-1 Inhibitor Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa PD-1 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa PD-1 Inhibitor Revenue Market Share by Countries in 2018
Figure Saudi Arabia PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure UAE PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Egypt PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure Nigeria PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Figure South Africa PD-1 Inhibitor Revenue and Growth Rate (2014-2019)
Table Global PD-1 Inhibitor Revenue (Million USD) by Type (2014-2019)
Table Global PD-1 Inhibitor Revenue Share by Type (2014-2019)
Figure Global PD-1 Inhibitor Revenue Share by Type (2014-2019)
Figure Global PD-1 Inhibitor Revenue Share by Type in 2018
Table Global PD-1 Inhibitor Revenue Forecast by Type (2019-2024)
Figure Global PD-1 Inhibitor Market Share Forecast by Type (2019-2024)
Figure Global Pembrolizumab Revenue Growth Rate (2014-2019)
Figure Global Nivolumab Revenue Growth Rate (2014-2019)
Figure Global Atezolizumab Revenue Growth Rate (2014-2019)
Figure Global Durvalumab Revenue Growth Rate (2014-2019)
Figure Global Avelumab Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global PD-1 Inhibitor Revenue by Application (2014-2019)
Table Global PD-1 Inhibitor Revenue Share by Application (2014-2019)
Figure Global PD-1 Inhibitor Revenue Share by Application (2014-2019)
Figure Global PD-1 Inhibitor Revenue Share by Application in 2018
Table Global PD-1 Inhibitor Revenue Forecast by Application (2019-2024)
Figure Global PD-1 Inhibitor Market Share Forecast by Application (2019-2024)
Figure Global Melanoma Revenue Growth Rate (2014-2019)
Figure Global Non-small Cell Lung Cancer (NSCLC) Revenue Growth Rate (2014-2019)
Figure Global Urothelial Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Classical Hodgkin Lymphoma Revenue Growth Rate (2014-2019)
Figure Global Renal Cell Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global PD-1 Inhibitor Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global PD-1 Inhibitor Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global PD-1 Inhibitor Revenue Market Share Forecast by Regions (2019-2024)
Figure North America PD-1 Inhibitor Revenue Market Forecast (2019-2024)
Figure Europe PD-1 Inhibitor Revenue Market Forecast (2019-2024)
Figure Asia-Pacific PD-1 Inhibitor Revenue Market Forecast (2019-2024)
Figure South America PD-1 Inhibitor Revenue Market Forecast (2019-2024)
Figure Middle East and Africa PD-1 Inhibitor Revenue Market Forecast (2019-2024)
世界のプラスミノーゲンアクチベーター阻害剤1市場2019 The global Plasminogen Activator Inhibitor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasminogen Activator Inhibitor 1 market status and forecast, categorizes the global Plasminogen …- 世界の血漿プロテアーゼC1阻害剤治療市場2019 The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Pl…
- 世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場：市場規模・現状・予測 PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, inclu…
- サイトカイン阻害剤市場：世界及び中国の市場分析・予測（～2024年） Cytokine Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cytokine Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cytokine Inhibitor manufacturers…
- 染料移行防止剤市場：世界及び中国市場分析・予測（～2024年） Dye Transfer Inhibitor Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Dye Transfer Inhibitor industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dye Transfer Inhibitor m…